A carregar...

Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency

Valproate (VPA) treatment in pregnancy leads to congenital anomalies, possibly by disrupting folate or homocysteine metabolism. Since methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of folate interconversion and homocysteine metabolism, we addressed the possibility that VPA might have di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Roy, Marc, Leclerc, Daniel, Wu, Qing, Gupta, Sapna, Kruger, Warren D., Rozen, Rima
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574752/
https://ncbi.nlm.nih.gov/pubmed/18615588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.21847
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!